Qatar Airways Cargo and Envirotainer have joined forces to offer sustainable solution for shipping temperature-sensitive pharmaceuticals to where they are needed most. By capitalising on both organisations’ extensive network capabilities, along with Envirotainer’s cutting-edge Releye® solution, CO2 emissions for shipments can be reduced by up to 90% compared to other solutions. The Releye® RLP and RLP solutions also ensure precise temperature control throughout the entire transportation process, meaning this partnership guarantees the utmost integrity and quality of temperature sensitive cargo like never before.
Miguel Rodriguez, Head of Cargo Products at Qatar Airways Cargo said: “I am thrilled to announce the reinforcement of our strategic partnership with Envirotainer, a global leader in temperature-controlled air transportation solutions. This collaboration marks a significant milestone for Qatar Airways Cargo as we continue to enhance our capabilities in delivering pharmaceuticals and other temperature-sensitive cargo worldwide. At Qatar Airways Cargo, we understand the criticality of maintaining the cold chain and ensuring that pharmaceuticals reach their destination in optimal conditions. By joining forces with Envirotainer, we can offer our customers seamless access to their industry-leading containers, which are specifically designed to meet the stringent requirements of the pharmaceutical industry.
Commenting on the partnership, Akos Balkanyi, Global Key Account Manager, expressed his enthusiasm, stating, “Through the optimisation of our operations and investment in cutting-edge solutions such the Releye® units, we are actively reducing our environmental impact and contributing to a greener future reducing up to 90% our CO2 emissions. We are excited about this collaboration and the positive impact it will have on our customers and the industry as a whole.”
The collaboration between Qatar Airways Cargo and Envirotainer underscores ongoing commitment of both organisations to investing in the latest technologies to meet the needs of the life sciences sector and is poised to make a long-term positive impact on customers and the industry for the future. Both organisations are excited about the possibilities that lie ahead, as they work together to ensure the safe transportation of pharmaceuticals and provide reliable and sustainable cold chain solutions that uphold the highest standards of quality, safety, and efficiency.